-
241
Optimization of a micro-scale air–liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2
Published 2025-01-01Subjects: Get full text
Article -
242
Immune responses in children with secondary infection of mycoplasma pneumoniae after COVID-19: focus on eosinophils and IgE
Published 2025-01-01Subjects: “…COVID-19 (SARS-CoV-2)…”
Get full text
Article -
243
Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 M<sup>pro</sup>
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
244
The incidence of outpatient care within 24 months from SARS-CoV-2 infection in the general population: a multicenter population-based cohort study
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
245
Safety and Intranasal Retention of a Broad-Spectrum Anti-SARS-CoV-2 Monoclonal Antibody SA55 Nasal Spray in Healthy Volunteers: A Phase I Clinical Trial
Published 2024-12-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
246
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics
Published 2025-02-01Subjects: Get full text
Article -
247
Plant-Based Antigen Production Strategy for SARS-CoV-2 Nucleoprotein and RBD and Its Application for Detection of Antibody Responses in COVID-19 Patients
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
248
Efeitos da Covid-19 na Atenção ao Câncer no Brasil: Impactos do Rastreamento ao Tratamento
Published 2025-02-01Subjects: Get full text
Article -
249
Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
Published 2025-01-01Subjects: Get full text
Article -
250
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2021Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
Get full text
Article -
251
The effects of deprivation, age, and regional differences in COVID-19 mortality from 2020 to 2022: a retrospective analysis of public provincial data
Published 2025-01-01Subjects: “…SARS-CoV-2 infection…”
Get full text
Article -
252
Comparative Analysis of COVID‐19 Severity and Mortality Among Vaccinated and Unvaccinated Individuals During the Delta Variant Surge in a Tertiary Care Center: A Cohort Study
Published 2025-01-01Subjects: “…severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2)…”
Get full text
Article -
253
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2023Subjects: Get full text
Article -
254
Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients
Published 2025-02-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
255
Long-Haul COVID: Investigating the Effects Within the Mauritian Context
Published 2025-01-01Subjects: “…post-acute sequelae of SARS-CoV-2 infection (PASC)…”
Get full text
Article -
256
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
Published 2025-01-01Subjects: Get full text
Article -
257
Population-Level SARS-CoV-2 RT–PCR Cycle Threshold Values and Their Relationships with COVID-19 Transmission and Outcome Metrics: A Time Series Analysis Across Pandemic Years
Published 2025-01-01Subjects: “…SARS-CoV-2 cycle threshold (Ct)…”
Get full text
Article -
258
Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
Published 2021Subjects: “…bee venom, complementary medicine and alternative medicine, SARS-CoV-2 (2019-nCoV), pharmokinetics of bee poison, COVID-19 and complementary medicine, bee venom in clinical trials…”
Get full text
Article